University of Oulu

C. Molins, A. Roldán, I. Corripio, M. Isohanni, J. Miettunen, J. Seppälä, A. Seppälä, H. Koponen, J. Moilanen, E. Jääskeläinen, Response to antipsychotic drugs in treatment-resistant schizophrenia: Conclusions based on systematic review, Schizophrenia Research, Volume 178, Issues 1–3, 2016, Pages 64-67, ISSN 0920-9964, https://doi.org/10.1016/j.schres.2016.09.016

Response to antipsychotic drugs in treatment-resistant schizophrenia : conclusions based on systematic review

Saved in:
Author: Molins, C.1; Roldán, A.1; Corripio, I.1;
Organizations: 1Department of Psychiatry, Institut d'Investigació Biomèdica-Sant Pau (IIB-SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
2Center for Life Course Health Research, University of Oulu, Oulu, Finland
3Department of Psychiatry, Oulu University Hospital, Oulu, Finland
4Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
5Research Unit for Clinical Neuroscience, Department of Psychiatry, University of Oulu, Oulu, Finland
6Department of Psychiatry, South-Savo Hospital District, Mikkeli, Finland
7Department of Psychiatry, Carea – Kymenlaakso Social and Health Services, Finland
8University of Helsinki and Helsinki University Hospital, Psychiatry, Finland
9A full list of m-RESIST Group authors and affiliations appears in www.mresist.eu
Format: article
Version: accepted version
Access: open
Online Access: PDF Full Text (PDF, 0.4 MB)
Persistent link: http://urn.fi/urn:nbn:fi-fe2018050219309
Language: English
Published: Elsevier, 2016
Publish Date: 2017-09-17
Series: Schizophrenia research
ISSN: 0920-9964
ISSN-E: 1573-2509
ISSN-L: 0920-9964
Volume: 178
Issue: 1-3
Pages: 64 - 67
DOI: 10.1016/j.schres.2016.09.016
OADOI: https://oadoi.org/10.1016/j.schres.2016.09.016
Type of Publication: A2 Review article in a scientific journal
Field of Science: 3112 Neurosciences
Subjects:
Funding: This study was supported by the European Union's Horizon 2020 research and innovation program under grant agreement No 643552, and in part by grant from the Brain and Behavior Research Foundation.
EU Grant Number: (643552) m-RESIST - Mobile Therapeutic Attention for Patients with Treatment Resistant Schizophrenia
Copyright information: © 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
  https://creativecommons.org/licenses/by-nc-nd/4.0/